FDA to launch pi­lot project for more trans­paren­cy on gener­ic drug de­lays

BETHES­DA, MD — The FDA is rolling out a new six-month pi­lot pro­gram to pro­vide more trans­paren­cy to gener­ic drug ap­pli­cants on com­pli­cat­ed reg­u­la­to­ry is­sues, Of­fice …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER